|
Re: We need news on the status of the Third Eye loan....
|
3
|
Resverlogix Corp.
|
Jan 31, 2019 06:56PM
|
|
Re: We need news on the status of the Third Eye loan....
|
2
|
Resverlogix Corp.
|
Jan 31, 2019 06:41PM
|
|
Re: We need news on the status of the Third Eye loan....
|
2
|
Resverlogix Corp.
|
Jan 31, 2019 06:27PM
|
|
Re: Hopefully we get news after the bell or before tomorrow's open
|
4
|
Resverlogix Corp.
|
Jan 30, 2019 09:51PM
|
|
Re: Hopefully we get news after the bell or before tomorrow's open
|
3
|
Resverlogix Corp.
|
Jan 30, 2019 02:23PM
|
|
Re: With all these emails to Sarah,..
|
1
|
Resverlogix Corp.
|
Jan 30, 2019 10:55AM
|
|
Re: With all these emails to Sarah,..
|
2
|
Resverlogix Corp.
|
Jan 30, 2019 10:41AM
|
|
Re: With all these emails to Sarah,..
|
2
|
Resverlogix Corp.
|
Jan 30, 2019 10:13AM
|
|
Re: What impact would a PR like this have?
|
3
|
Resverlogix Corp.
|
Jan 30, 2019 08:03AM
|
|
Re: Adjudication
|
3
|
Resverlogix Corp.
|
Jan 30, 2019 07:37AM
|
|
Re: Adjudication
|
2
|
Resverlogix Corp.
|
Jan 30, 2019 06:44AM
|
|
Re: Adjudication
|
1
|
Resverlogix Corp.
|
Jan 30, 2019 05:47AM
|
|
The Problem with Composite End Points in Cardio Studies ........
|
3
|
Resverlogix Corp.
|
Jan 28, 2019 11:07PM
|
|
What Big Pharma is thinking.
|
2
|
Resverlogix Corp.
|
Jan 28, 2019 08:40PM
|
|
Re: Estimation of clinical trial success rates and related parameters
|
4
|
Resverlogix Corp.
|
Jan 27, 2019 10:20PM
|
|
Re: Interesting paper on BET inhibitors and Memory
|
3
|
Resverlogix Corp.
|
Jan 27, 2019 09:58PM
|
|
Re: Interesting paper on BET inhibitors and Memory
|
2
|
Resverlogix Corp.
|
Jan 27, 2019 09:10PM
|
|
Re: Interesting Trades / Volume .....
|
4
|
Resverlogix Corp.
|
Jan 27, 2019 09:06PM
|
|
Re: Interesting Trades / Volume .....
|
3
|
Resverlogix Corp.
|
Jan 27, 2019 08:51PM
|
|
Re: Interesting Trades / Volume .....
|
4
|
Resverlogix Corp.
|
Jan 27, 2019 08:46PM
|
